Buy 1D-LSD 225 mcg Pellets – Premium Lysergamide | euro-labchems.com

Buy 1D-LSD 225 mcg Pellets (1-(1,2-Dimethylcyclobutane-1-carbonyl)-LSD) CAS Number: Not formally assigned (novel lysergamide, SYN-L-229 reference) Molecular Formula: C₂₇H₃₅N₃O₂ Molecular Weight: 433.6 g/mol Purity: ≥98.5% (HPLC verified) Dosage per pellet: Precisely 225 mcg 1D-LSD Form: Compressed pharmaceutical-grade pellets (uniform, scored for accuracy) Quantity options: 5, 10, 25, 50, 100 pellets Shipping: Discreet worldwide, vacuum-sealed, moisture-proof packaging

euro-labchems.com supplies high-purity 1D-LSD 225 mcg pellets – a contemporary lysergamide prodrug analog of LSD, featuring a 1,2-dimethylcyclobutane-1-carbonyl group at the N1 position. Emerging around 2022–2023 as a successor to 1V-LSD (following regulatory changes in regions like Germany), 1D-LSD is presumed to metabolize rapidly in vivo to active LSD, delivering reliable psychedelic effects with a faster onset and potentially shorter duration.

What is 1D-LSD?

1D-LSD (1-(1,2-dimethylcyclobutane-1-carbonyl)-d-lysergic acid diethylamide), also known as SYN-L-229, is a novel research lysergamide and prodrug of LSD in the substituted lysergamide family. It supports advanced studies in serotonin receptor pharmacology, neuroplasticity, and behavioral models.

Key Product Specifications of 1D-LSD 225 mcg Pellets

• Pellet size: Small, consistent 3–4 mm diameter
• Excipients: Inert binders for stability & precise dosing
• Stability: Excellent cool/dark/dry storage (2+ years)
• Potency: 225 mcg per pellet – strong/full research dose (comparable to ~150–225 μg LSD equivalents in prodrug models)

Research Effects & Characteristics

Duration: 6–10 hours (quicker onset, shorter plateau vs classic LSD) Onset: 20–60 minutes (notably rapid) Peak: 2–5 hours

Literature indicates LSD-like effects: intense visual hallucinations (geometric patterns, color enhancement, breathing surfaces), time distortion, profound introspection, euphoria, synesthesia, music amplification, conceptual enhancement, and potential ego dissolution. At 225 mcg, 1D-LSD provides a robust psychedelic profile for neuropharmacological research.

Possible side effects (dose-dependent): mild come-up nausea, elevated heart rate/blood pressure, anxiety/paranoia in unsuitable settings, insomnia, appetite suppression, rare persisting perceptual changes (HPPD-like).

1D-LSD 225 mcg pellets are sold strictly for scientific research – not for human/veterinary use. Verify local regulations. Full CoA available.

Discover next-generation lysergamide precision with 1D-LSD from euro-labchems.com – your trusted research specialist.